Greater Wellington Water are using S::Can Spectro::Lysers at full-scale to successfully manage Disinfection By-Products - Chris Laidlow

Water/wastewater

Greater Wellington Water are using S::Can Spectro::Lysers at full-scale to successfully manage Disinfection By-Products - Chris Laidlow

14 Mar, 2011

Published over 15 years ago. See the latest and most current information on Water/wastewater.

Chris Laidlow
1 min read
Download

Greater Wellington Water (New Zealand) operates two surface water treatment plants. These are the 140ML/d Te Marua WTP and the 60ML/d Wainuiomata WTP. Both of these sites treat water from heavily forested upland catchments. The source water is very low in turbidity and has highly variable NOM content. The NOM is predominantly humic and fulvic acids with a high THM and HAA formation potential. The average normalised formation potentials for the plants are:

Total THM formation potential = 75.3 μg/mg C

HAA5 formation potential = 100.9 μg/mg C

Each of the plants has 4 s::can spectro::lysers installed for source selection, coagulation control (Com::pass), plant monitoring and chlorine dose setpoint control.

Despite the relatively high levels of both total THMS and HAA5s in the source waters the concentrations measured in the distribution system are always <20μg/L and <50μg/L for total THMs and HAA5s respectively.

On-line measurements of TTHM formation potential and HAA5 formation potential are shown for the Te Marua WTP inlet and combined filtered water in the following graphs.

Latest Articles

IET 36.3 May

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Review suggests eating less protein could extend healthy lifespan in inactive adults
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
ASTM D8615 brings automated freezing-point testing into aviation fuel laboratories
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow